News | December 29, 2014

Mammography Market Value in the Americas Projected Beyond $1 Billion by 2020

U.S. market will lead the way, with 3-D systems overtaking 2-D by 2016; 2-D demand to remain high in other countries

December 29, 2014 — The market value of mammography systems in the Americas will increase from approximately $390 million in 2013 to $1.1 billion by 2020, according to business intelligence provider GBI Research, driven primarily by the uptake of 3-D systems in the United States and healthy demand for 2-D systems in Canada, Mexico and Brazil.

The company’s latest report states that the United States will continue to hold the dominant share, with its overall market value forecast to exceed $925 million by 2020.

Furthermore, U.S. 3-D systems revenue will rise from $99.2 million in 2013 to just over $757 million by 2020, representing a compound annual growth rate (CAGR) of 34 percent, while 2-D systems sales will decline at a negative CAGR of 4 percent.

Srikanth Venkataraman, senior analyst for GBI Research, says: “The remarkable expansion of the U.S. market will be caused by continuous replacement of 2-D systems with 3-D systems.

“The rapid adoption of 3-D systems in the United States is due to technical advantages, such as improved breast cancer detection rate, the ability to handle higher procedure volumes and a more favorable reimbursement scenario.”

U.S. sales of 3-D systems will increase year-on-year during the forecast period and will overtake the falling 2-D market in 2016. The gap will continue to widen thereafter, although the U.S. 2-D space will still be worth over $168 million by 2020, more than the entire Canadian and Mexican mammography markets combined.

GBI Research forecasts that Canada’s share will rise from $23.7 million in 2013 to $78.9 million by 2020, at a slightly faster rate than the United States, while the Mexican sector will expand from $14.8 million to $33.3 million over the same period. The Brazilian market is expected to more than triple from $14.9 million in 2013 to approximately $47 million by 2020.

Venkataraman explains: “Strong demand for 2-D systems will continue in Canada, Mexico and Brazil, as high upfront cost limits the adoption of 3-D systems in small hospitals and imaging centers with significant budget constraints.”

For more information:

Related Content

Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Biop Medical cervical cancer detection system

Technology | Women's Health | November 13, 2017
November 13, 2017 — Biop Medical announced it will present its point-of-care...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Kubtec Brings Image Analytics Capabilities to Tomosynthesis Specimen Imaging Systems
News | Mammography | November 10, 2017
Kubtec announced it will be showcasing new image analytics capabilities on its advanced tomosynthesis specimen imaging...
Siemens Healthineers Introduces Share360 Tailored Service Portfolio
News | Imaging | November 10, 2017
November 10, 2017 — To address the specific needs of...
Fujifilm Highlights Women's Health and Pediatrics at RSNA 2017
News | Information Technology | November 08, 2017
November 8, 2017 — Fujifilm Healthcare will showcase a variety of imaging and information technology solutions at the
CureMetrix Expands Medical Advisory Board
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
ICPME Makes EQUIP Mammography Inspection CME/CE Webinar Available Online
News | Mammography | November 08, 2017
November 8, 2017 — In conjunction with Brea...
Study Suggests Breast Cancer Patients Forego Post-Surgery Treatment Due to Mistrust
News | Radiation Therapy | November 06, 2017
November 6, 2017 — Nearly one-third of women with...
Study shows tissue marker reduces radiation target volumes, produces many other advantages

These CT images show placement of a 3-D fixed array implanted fiducial (3-D marker) at the time of oncoplastic tumor resection. The original LCTV (LCTVo) was retrospectively re-contoured by the radiation oncologist (LCTVro) and breast surgeon (LCTVbs). Thereafter, both re-contours were combined to create the collaborative LCTV (LCTVc), which required agreement of both the radiation oncologist and breast surgeon. Volume differences between the original LCTV (LCTVo) and the collaborative LCTVc were then evaluated, and demonstrated a mean and median reduction in LCTV.

Feature | Tumor Tracking Systems | November 06, 2017 | By William Hall, M.D.
Radiation planning for breast cancer relies on accurate delineation of the post-lumpectomy target volume as identified...
Blood Test Rules Out Breast Cancer Regardless of Density
News | Oncology Diagnostics | November 03, 2017
November 3, 2017 — A new study published in ...
Overlay Init